Dr Necchi on Molecular Data With Perioperative Sacituzumab Govitecan Plus Pembrolizumab in MIBC
“The story [of these data are] pretty consistent [with] the classical biomarker associated with immunotherapy: higher tumor mutational burden portended…
Dr Necchi on Molecular Data With Perioperative Sacituzumab Govitecan Plus Pembrolizumab in MIBC Read More